Trial intelligence / Profile preview

Double-blind randomized controlled study of intra-arterial bone marrow progenitor cell transplantation for chronic ischemia in peripheral arterial disease

2005-000968-33Phase 4Completed

Sponsor
Cardiology Department, Goethe University Frankfurt
Start
Mar 2005
Modality
Adoptive Cell Transfer → Cell Therapies, Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of autologous bone marrow-derived progenitor cells in arteriosclerosis obliterans and chronic limb-threatening ischaemia (CLTI) (2 arms), sponsored by Cardiology Department, Goethe University Frankfurt. Started Mar 2005; status: completed.

02

Drugs

autologous bone marrow-derived progenitor cells
03

Conditions

arteriosclerosis obliteranschronic limb-threatening ischaemia (CLTI)

Beyond the preview

Go deeper on 2005-000968-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-000968-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call